Stage IVC Thyroid Gland Follicular Carcinoma AJCC v7
specificStage IV includes: IVA (T4a, N0, M0); (T4a, N1a, M0); (T1, N1b, M0); (T2, N1b, M0); (T3, N1b, M0); (T4a, N1b, M0); IVB (T4b, Any N, M0); IVC (Any T, Any N, M1). T4a: Moderately advanced local disease. Tumor of any size extending beyond the thyroid gland capsule to invade subcutaneous soft tissues, larynx, trachea, esophagus, or recurrent laryngeal nerve. T1: Tumor size 2 cm or less in greatest dimension, limited to the thyroid gland. T2: Tumor more than 2 cm but not more than 4 cm in greatest
11
Centers
1
Active Trials
—
Cancer Funding
Top Centers for Stage IVC Thyroid Gland Follicular Carcinoma AJCC v7(11)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | Memorial Sloan Kettering Cancer CenterNew York, NY NCI Comprehensive High-Volume Research Center | 75.0 |
| 2 | Dana-Farber Cancer InstituteBoston, MA NCI Comprehensive | 52.5 |
| 3 | Mayo Clinic Comprehensive Cancer CenterRochester, MN NCI Comprehensive | 52.5 |
| 4 | Vanderbilt-Ingram Cancer CenterNashville, TN NCI Comprehensive | 52.5 |
| 5 | UC San Diego Moores Cancer CenterLa Jolla, CA NCI Comprehensive | 52.5 |
| 6 | Duke Cancer InstituteDurham, NC NCI Comprehensive | 52.5 |
| 7 | The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH NCI Comprehensive | 52.5 |
| 8 | University of Colorado Cancer CenterAurora, CO NCI Comprehensive | 52.5 |
| 9 | Medical College of Wisconsin Cancer CenterMilwaukee, WI | 52.5 |
| 10 | University of Illinois Cancer CenterChicago, IL | 52.5 |
| 11 | Boston University Cancer CenterBoston, MA | 52.5 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →